# AGC Biologics, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/agc-biologics-inc/9759f733-dd5f-4f2e-a516-f1b37fad39e2

> Inspection records and compliance data for AGC Biologics, Inc. in SE and 22021 20th Ave, SE. Access full analysis and detailed observations.

---

## Details

- Name: AGC Biologics, Inc.
- FEI Number: 3000209996
- City: SE and 22021 20th Ave
- State: SE
- Country Name: WA 98021
- Address Line 1: 21511 23rd Dr.
- Zip Code: Bothell

## Related Documents

- [483 - AGC Biologics, Inc. - Unknown Date](https://www.keypedia.com/records/483/agc-biologics-inc/68b9608f-4ced-445d-97ca-dbe85c33ee88) — source: FDA, date: Invalid Date
- [483 - AGC Biologics, Inc. - Unknown Date](https://www.keypedia.com/records/483/agc-biologics-inc/361f2f05-4042-44c5-985a-e95863e25cc0) — source: FDA, date: Invalid Date
- [483 - AGC Biologics, Inc. - Unknown Date](https://www.keypedia.com/records/483/agc-biologics-inc/f364fb7c-8e0e-47cb-905e-2ec30672b2c1) — source: FDA, date: Invalid Date
- [483 - AGC Biologics, Inc. - 2025-04-18](https://www.keypedia.com/records/483/agc-biologics-inc/5feb9b19-4203-4a42-8153-4c5ad2c4aa43) — source: FDA, date: April 18, 2025
- [FDA Inspection 1265749 - AGC Biologics, Inc. - 2025-04-18](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/4b5c17f5-89e1-4c63-b2e1-24bd1241af59) — source: FDA, date: April 18, 2025
- [FDA Inspection 1265749 - AGC Biologics, Inc. - 2025-04-18](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/775242ad-2e18-4239-b13a-437601702335) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 18, 2025
- [483 - AGC Biologics, Inc. - 2024-03-27](https://www.keypedia.com/records/483/agc-biologics-inc/1ae2bd69-95b9-4aa9-8673-4ed83ff4a444) — source: FDA, date: March 27, 2024
- [FDA Inspection 1231895 - AGC Biologics, Inc. - 2024-03-27](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/c82be910-e28a-4ee7-a190-b28bd65abc66) — source: FDA, date: March 27, 2024
- [483 - AGC Biologics, Inc. - 2023-02-10](https://www.keypedia.com/records/483/agc-biologics-inc/642c5042-ad56-4c71-91da-5d256a20fc36) — source: FDA, date: February 10, 2023
- [483 - AGC Biologics, Inc. - 2023-02-10](https://www.keypedia.com/records/483/agc-biologics-inc/29068fb0-b901-4b27-8d6c-480f07b9d85d) — source: FDA, date: February 10, 2023
- [FDA Inspection 1197098 - AGC Biologics, Inc. - 2023-02-10](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/a215b082-8d02-46ce-9fcd-9a697cc9dea5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2023
- [EIR - AGC Biologics, Inc. - 2021-07-23](https://www.keypedia.com/records/eir/agc-biologics-inc/018c23f4-6b30-46f0-a167-ffc910d3fe5a) — source: FDA, date: July 23, 2021
- [FDA Inspection 1149254 - AGC Biologics, Inc. - 2021-07-23](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/c64c9870-4b2a-41b0-8194-185591ff15f1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 23, 2021
- [483 - AGC Biologics, Inc. - 2021-07-12](https://www.keypedia.com/records/483/agc-biologics-inc/532e4a4a-b139-4ca7-8e67-b3ee13096e7d) — source: FDA, date: July 12, 2021
- [483 - AGC Biologics, Inc. - 2021-03-19](https://www.keypedia.com/records/483/agc-biologics-inc/81edf986-e83a-4445-85ad-bcc668cfe51e) — source: FDA, date: March 19, 2021
- [FDA Inspection 1109813 - AGC Biologics, Inc. - 2018-10-15](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/637ed58c-aa5a-437a-8630-16864734811d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2018
- [FDA Inspection 930335 - AGC Biologics, Inc. - 2015-05-15](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/dff4b2f7-993a-48d8-bcb9-85a671592242) — classification: No Action Indicated (NAI), source: FDA, date: May 15, 2015
- [FDA Inspection 779103 - AGC Biologics, Inc. - 2012-04-18](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/6f32386e-9fbb-45d1-88bb-78c6c4318828) — classification: No Action Indicated (NAI), source: FDA, date: April 18, 2012
- [FDA Inspection 562746 - AGC Biologics, Inc. - 2009-02-13](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/3b5a7114-5c01-485e-9fd4-10b2aca8420c) — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2009

## Related Companies

- [FujiFilm Diosynth Biotechnologies U.S.A., Inc.](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-usa-inc/44b7fa9f-848c-4e30-869e-12ddcfd848f8)
- [Global Calcium Pvt. Limited](https://www.keypedia.com/companies/global-calcium-pvt-limited/274540f7-e7a4-47fb-b3a0-61fb5e85d807)
- [Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.)](https://www.keypedia.com/companies/amoli-organics-a-division-of-umedica-laboratories-pvt-ltd/b8bc3797-9fd3-4e78-a475-bc53b2f5310e)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/ad3c6024-a4cc-403f-86ab-fe86668ef0bc)
- [Catalent Maryland Inc](https://www.keypedia.com/companies/catalent-maryland-inc/fbdaa987-e6a7-466f-b42b-1f23193725d8)
- [Daiichi Sankyo Chemical Pharma Co., Ltd.](https://www.keypedia.com/companies/daiichi-sankyo-chemical-pharma-co-ltd/846f1b3f-281e-4616-ae05-902bf9bcb28c)
- [Agilent Technologies Inc](https://www.keypedia.com/companies/agilent-technologies-inc/865fe026-9db0-4e3e-bc4a-e0d25b465093)
- [Polpharma Biologics S.A](https://www.keypedia.com/companies/polpharma-biologics-sa/cbcf90aa-e0dc-4cd8-90ab-3389315441d8)
- [Curia India Private Limited](https://www.keypedia.com/companies/curia-india-private-limited/957a813a-fe8f-4ea0-92bb-b16a25119979)
- [Zhejiang Peptites Biotech Co.,Ltd.](https://www.keypedia.com/companies/zhejiang-peptites-biotech-coltd/e2ec39f6-5557-4a89-bf23-65edb9d36a4e)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/arie-c-menachem/01bacbef-a3ae-4eb0-a56f-e8a70b67a524)
- [Colleen Hoyt](https://www.keypedia.com/people/colleen-hoyt/2a9c0d42-46de-4c53-820f-64468eb3e608)
- [company_representative](https://www.keypedia.com/people/lisa-a-eberle/328d2549-689c-43a9-bc26-894478628a95)
- [company_representative](https://www.keypedia.com/people/andy-walker/35b571c1-19ef-4d86-9302-39acc0233aef)
- [Andrew "Drew" Haack, Ph.D., Consumer Safety Officer](https://www.keypedia.com/people/andrew-drew-haack-phd-consumer-safety-officer/811ef591-706b-45d8-8c22-2d985d8fd1f7)
- [Michael Araneta, MPH, Supervisory Consumer Safety Officer](https://www.keypedia.com/people/michael-araneta-mph-supervisory-consumer-safety-officer/147e7665-39f6-4706-9828-4f1e631f09ce)